Sjogren Syndrome Antigen B (SSB) Peptid
SSB
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939535
Kurzübersicht für Sjogren Syndrome Antigen B (SSB) Peptid (ABIN939535)
Target
SSB
(Sjogren Syndrome Antigen B (SSB))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- ISEDKTKIRR SPSKPLPEVT DEYKNDVKNR SVYIKGFPTD ATLDDIKEWL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSB antibody,
Alternative Names: SSB control peptide, SSB antibody Blocking Peptide, Anti-SSB Blocking Peptide, Sjogren Syndrome Antigen B Blocking Peptide, Autoantigen La Blocking Peptide, LARP3 Blocking Peptide, La Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SSB (Sjogren Syndrome Antigen B (SSB))
-
Hintergrund
- SSB is involved in diverse aspects of RNA metabolism, including binding and protecting 3-prime UUU(OH) elements of newly RNA polymerase III-transcribed RNA, processing 5-prime and 3-prime ends of pre-tRNA precursors, acting as an RNA chaperone, and binding viral RNAs associated with hepatitis C virus. SSB protein was originally defined by its reactivity with autoantibodies from patients with Sjogren syndrome and systemic lupus erythematosus.
-
Molekulargewicht
- 45 kDa
Target
-
Sie sind hier:
